- Report
- January 2026
- 194 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- August 2026
- 396 Pages
Global
From €5255EUR$5,850USD£4,501GBP
- Report
- January 2026
- 145 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- July 2026
- 160 Pages
Global
From €3728EUR$4,150USD£3,193GBP
- Report
- February 2026
- 268 Pages
Global
From €4447EUR$4,950USD£3,809GBP
- Report
- April 2026
- 137 Pages
Global
From €2694EUR$2,999USD£2,308GBP
€3592EUR$3,999USD£3,077GBP
- Report
- April 2026
- 141 Pages
Global
From €2694EUR$2,999USD£2,308GBP
€3592EUR$3,999USD£3,077GBP
- Report
- March 2026
- 110 Pages
Global
From €5345EUR$5,950USD£4,578GBP
- Report
- March 2026
- 150 Pages
Global
From €5345EUR$5,950USD£4,578GBP
- Report
- January 2026
- 197 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 190 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- May 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- April 2026
- 106 Pages
Global
From €3500EUR$4,174USD£3,103GBP
- Newsletter
- August 2026
- 75 Pages
Global
€4267EUR$4,750USD£3,655GBP

The Demineralized Bone Matrix (DBM) market is a subset of the larger biomaterials industry. DBM is a type of bone graft material that is used to repair and regenerate bone tissue. It is composed of collagen and other proteins, and is processed to remove the mineral content. DBM is used in a variety of orthopedic and dental procedures, including spinal fusion, fracture repair, and dental implantation. It is also used in reconstructive surgery, such as facial reconstruction.
DBM is a growing market, with increasing demand for its use in a variety of medical procedures. It is a cost-effective alternative to autografts, and is gaining popularity due to its biocompatibility and ability to promote bone regeneration.
Some companies in the DBM market include Zimmer Biomet, Medtronic, Stryker, and Orthofix. Show Less Read more